Summary
- Current Price
- As of today, PTGX price is $142.84, down -0.39% on
- Current Price All-Time High
- PTGX price is currently -11.17% below its historical high of $160.81 set on
- Market Cap
- PTGX current market cap is $9B, up +151.30% over the past 365 days
- PE Ratio
- PTGX current PE ratio is 137.74
- Revenue
- PTGX current annual revenue is $46.02M, down -89.41% year-over-year
- Next Earnings
- The next earnings release for PTGX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Protagonist Therapeutics, Inc. |
| Ticker | NASDAQ: PTGX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | protagonist-inc.com |
| Employees | 124 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $142.84 | |
| Price, 1D Change | -0.39% | |
| $9B | ||
| - | ||
| 137.74 | ||
| 0.18 | ||
| $46.02M | ||
| Revenue, 1Y Change | -89.41% | |
| -$2.05 | ||
| EPS, 1Y Change | -148.41% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.05 | ||
| EPS Estimate | $4.79 | N/A |
| EPS Est. Change | +334.11% | N/A |
| $46.02M | ||
| Revenue Estimate | $542.27M | N/A |
| Revenue Est. Change | +1,078.44% | N/A |
| Current Price | $142.84 | |
| Price Target | $171.00 | - |
| Price Tgt. Change | +19.71% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.63 | $4.23 | +60.61% | |
| -$1.87 | -$2.05 | -9.29% | |
| $4.79 | N/A | +334.11% | |
| -$0.20 | N/A | +90.27% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $320.75M | $434.43M | +35.44% | |
| $50.48M | $46.02M | -8.84% | |
| $542.27M | N/A | +1,078.44% | |
| $203.41M | N/A | +342.05% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $142.84 | |
| $108.12 | ||
| $143.46 | ||
| $112.26 | ||
| $141.01 | ||
| $0.17 | ||
| 0.18 | ||
| $5.56 | ||
| 44.72 | ||
| 24.20% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $46.02M | ||
| -$2.05 | ||
| $44.79M | ||
| 97.34% | ||
| -$158.13M | ||
| -343.63% | ||
| -$130.15M | ||
| -282.83% | ||
| -$156.90M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.02 | ||
| 12.71 | ||
| 12.71 | ||
| - | ||
| 8 | ||
| 99.75 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 137.74 | ||
| 32.78 | ||
| 10.98 | ||
| 141.44 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $614.71M | ||
| $567.36M | ||
| $669.89M | ||
| $577.57M | ||
| $55.19M | ||
| $45.44M | ||
| $10.32M | ||
| $2.28M | ||
| $5.34M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $176.17M | ||
| $202.92M | ||
| $1.23M | ||
| $0.00 | ||
| $1.28M | ||
| $0.00 | ||
| $838.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $57.67M | ||
| -$49.33M | ||
| $22.86M | ||
| $1.59M | ||
| $56.08M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| BMO Capital | → | |
| Barclays | → | |
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| BMO Capital | → | |
| Wedbush | → | |
| Truist Securities | → | |
| Goldman Sachs | → | |
| Citigroup | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
No data
Screeners with PTGX
FAQ
- What is the ticker symbol for Protagonist Therapeutics, Inc.?
- The ticker symbol for Protagonist Therapeutics, Inc. is NASDAQ:PTGX
- Does Protagonist Therapeutics, Inc. pay dividends?
- No, Protagonist Therapeutics, Inc. does not pay dividends
- What sector is Protagonist Therapeutics, Inc. in?
- Protagonist Therapeutics, Inc. is in the Healthcare sector
- What industry is Protagonist Therapeutics, Inc. in?
- Protagonist Therapeutics, Inc. is in the Biotechnology industry
- What country is Protagonist Therapeutics, Inc. based in?
- Protagonist Therapeutics, Inc. is headquartered in United States
- When did Protagonist Therapeutics, Inc. go public?
- Protagonist Therapeutics, Inc. initial public offering (IPO) was on August 11, 2016
- Is Protagonist Therapeutics, Inc. in the S&P 500?
- No, Protagonist Therapeutics, Inc. is not included in the S&P 500 index
- Is Protagonist Therapeutics, Inc. in the NASDAQ 100?
- No, Protagonist Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Protagonist Therapeutics, Inc. in the Dow Jones?
- No, Protagonist Therapeutics, Inc. is not included in the Dow Jones index
- When was Protagonist Therapeutics, Inc. last earnings report?
- Protagonist Therapeutics, Inc.'s most recent earnings report was on August 5, 2026
- When does Protagonist Therapeutics, Inc. report earnings?
- The next expected earnings date for Protagonist Therapeutics, Inc. is November 5, 2026
Data Sources & References
- PTGX Official Website www.protagonist-inc.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1377121/000110465926019696/0001104659-26-019696-index.htm
- PTGX Profile on Yahoo Finance finance.yahoo.com/quote/PTGX
- PTGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ptgx